Naoko Aoki
Asahikawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A Case of Adenocarcinoma in a Stoma Site after 27 Years of Stoma Surgery for Hirschsprung's Disease.
A Case of Adenocarcinoma in a Stoma Site after 27 Years of Stoma Surgery for Hirschsprung's Disease.
Journal: Surgical case reports
Published: February 24, 2026
Primary Biliary Cholangitis-Associated Granulomatous Interstitial Lung Disease: Pulmonary Epithelial-Interface Injury Supporting the Concept of Generalized Autoimmune Epithelitis.
Journal: Pathology international
Published: February 16, 2026
CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases: A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues.
Journal: Current oncology (Toronto, Ont.)
Published: February 03, 2026
Bursitis in the nonarticular part of the mandible in atopic dermatitis.
Journal: Oral and maxillofacial surgery
Published: August 08, 2024
Ectopic epipericardial fat necrosis: a case report.
Journal: Surgical case reports
Published: September 26, 2023
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes.
Journal: The Journal of experimental medicine
Published: April 27, 2020
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Journal: Journal of translational medicine
Published: January 31, 2019
Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb.
Journal: Biochemical and biophysical research communications
Published: June 12, 2017
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: October 18, 2016
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Journal: Cancer immunology, immunotherapy : CII
Published: October 02, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.
Journal: Oncoimmunology
Published: January 25, 2016
Last Updated: 09/26/2026